- Home
- ESS vs ZBH Comparison
ESS vs ZBH Comparison
Compare ESS & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESS
- ZBH
- Stock Information
- Founded
- ESS 1971
- ZBH 1927
- Country
- ESS United States
- ZBH United States
- Employees
- ESS N/A
- ZBH N/A
- Industry
- ESS Real Estate Investment Trusts
- ZBH Industrial Specialties
- Sector
- ESS Real Estate
- ZBH Health Care
- Exchange
- ESS Nasdaq
- ZBH Nasdaq
- Market Cap
- ESS 19.4B
- ZBH 20.8B
- IPO Year
- ESS 1994
- ZBH N/A
- Fundamental
- Price
- ESS $301.79
- ZBH $112.53
- Analyst Decision
- ESS Hold
- ZBH Hold
- Analyst Count
- ESS 20
- ZBH 22
- Target Price
- ESS $282.37
- ZBH $124.40
- AVG Volume (30 Days)
- ESS 367.5K
- ZBH 1.6M
- Earning Date
- ESS 10-29-2024
- ZBH 10-30-2024
- Dividend Yield
- ESS 3.25%
- ZBH 0.85%
- EPS Growth
- ESS 4.83
- ZBH 132.72
- EPS
- ESS 8.56
- ZBH 5.26
- Revenue
- ESS $1,752,440,000.00
- ZBH $7,595,500,000.00
- Revenue This Year
- ESS N/A
- ZBH $4.76
- Revenue Next Year
- ESS $4.40
- ZBH $4.63
- P/E Ratio
- ESS $35.26
- ZBH $21.41
- Revenue Growth
- ESS 3.18
- ZBH 4.35
- 52 Week Low
- ESS $209.17
- ZBH $101.47
- 52 Week High
- ESS $317.73
- ZBH $133.90
- Technical
- Relative Strength Index (RSI)
- ESS 54.92
- ZBH 64.45
- Support Level
- ESS $300.73
- ZBH $107.51
- Resistance Level
- ESS $308.37
- ZBH $112.83
- Average True Range (ATR)
- ESS 6.51
- ZBH 2.36
- MACD
- ESS 1.44
- ZBH 0.45
- Stochastic Oscillator
- ESS 79.92
- ZBH 96.97
About ESS Essex Property Trust Inc.
Essex Property Trust owns a portfolio of 254 apartment communities with over 62,000 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.